Monthly Archives: August 2020

Daily Market Analysis Market Focus U.S. markets drift slightly higher as investors assess economic reports and a resurgence of coronavirus cases in Europe. Economic data from most of euro- area seem to worsen than expected, except the U.K. Europe is grappling with a resurgence of pandemic infections, with little appetite amid top officials to resortContinue Reading

Daily Market Analysis Market Focus Stocks climbed as gains in giant technology companies drove the Nasdaq 100 to a record, tempering concern that a recovery from the pandemic-induced recession will need more time. Treasuries rose. The rally in heavyweights such as Apple Inc. and Tesla Inc. offset a slide for energy producers and banks amid light trading volume. Earlier Thursday, equitiesContinue Reading

Daily Market Analysis Market Focus Stocks are slightly higher after closing at a record for the first time since COVID-19 started amid a rebound in giant technology companies. Major indexes advance as investors are waiting for the latest stimulus plan discussion ahead of the Federal Reserve’s meeting minutes. In the meanwhile, investors are putting theContinue Reading

Daily Market Analysis Market Focus Major U.S. indexes climb, buoyed by Chinese stimulus overnight, as of writing. The S&P 500 aims at its before the pandemic closing- record; the Nasdaq outperforms as a jump in several technological companies. In the meanwhile, China has decided to roll over medium- term loans and keep borrowing costs constantlyContinue Reading

Daily Market Analysis Market Focus   US equity market was mixed as stimulus negotiations linger. The White House and the Treasury is $1 trillion away from reaching a deal, “we have made clear to the administration that we are willing to come down $1 trillion if they will come up $1 trillion. We are willingContinue Reading

Daily Market Analysis Market Focus An American biotechnological company, Moderna Inc. reached an unprecedented deal of $1.5 billion with the Trump administration to supply 100 million does of its experimental vaccine for COVID-19. Under the deal, Moderna Inc. will provide about 100 million does, with the price of around $30.50 per person. In the meantime,Continue Reading

Daily Market Analysis Market Focus President Donald Trump is considering a tax cut on capital gains and American hospitalization for coronavirus fell to their lowest in a month. “We’re considering a capital tax cut, which could create a lot more jobs,” Trump said on the White House news conference. The president has to issue anContinue Reading

Daily Market Analysis Market Focus U.S. market was fluctuating with mixed information. Dow Jones gained as investors considered more earning results and potential outcomes for coronavirus- related stimulus. Despite of failing to make progress on a new coronavirus stimulus plan last week, raising the uncertainty about U.S. economy recovery, investors kept up their hope onContinue Reading

Daily Market Analysis Market Focus   US and European equity edged higher amid encouraging news on the vaccine front. Novavax joins the ranks of AstraZeneca Plc, Moderna Inc., Pfizer Inc. and BioNTech SE which has all reported Phase 1 results for the COVID-19 vaccine. The S&P 500 Index headed for a fourth consecutive rise.  Continue Reading

Daily Market Analysis Market Focus   US equity advanced as positive economic data outweighed pandemic pessimism. The White House is concerned about the economic impact of the benefits having expired on Friday, and was said to consider acting on its own to boost unemployment benefits, however it wasn’t immediately clear how Trump administration may beContinue Reading